Significant Ownership of Stonepine Capital Management, LLC

Signature - Title
/s/ Jon M. Plexico - Managing Member
Location
Bend, OR
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Stonepine Capital Management, LLC.

Notify me when Stonepine Capital Management, LLC files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Stonepine Capital Management, LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
QNRX Quoin Pharmaceuticals, Ltd. Ordinary Shares 9.9% $62.8M 3.03M Stonepine Capital Management, LLC 10 Dec 2025
INAB IN8BIO, Inc. Common Stock 9.9% $1.98M 1.01M Stonepine Capital Management, LLC 19 Dec 2025
AYTU AYTU BIOPHARMA, INC Common Stock 9.9% $1.98M 906K Stonepine Capital Management, LLC 30 Jun 2025
EDSA Edesa Biotech, Inc. Common Stock 9.9% $1.64M 694K Stonepine Capital Management, LLC 13 Feb 2025
OPTN OptiNose, Inc. Common Stock 7.8% $7.18M $1.82M 789K +34% Stonepine Capital Management, LLC 31 Mar 2025
TELA TELA Bio, Inc. Common Stock 6% $2.21M 2.35M Stonepine Capital Management, LLC 31 Dec 2024
SRZN Surrozen, Inc./DE Common Stock 5.8% $4.48M $1.55M 509K +53% Stonepine Capital Management, LLC 30 Jun 2025
CNSP CNS Pharmaceuticals, Inc. Common Stock 5.6% $290K 32.2K Stonepine Capital Management, LLC 29 Oct 2025
KZR Kezar Life Sciences, Inc. Common Stock 5.2% $1.63M 377K Stonepine Capital Management, LLC 02 Sep 2025
CALC CalciMedica, Inc. Common Stock 4.6% $949K -$171K 629K -15.2% Stonepine Capital Management, LLC 31 Mar 2025
VSTM Verastem, Inc. Common Stock 4.3% $23.6M -$1.44M 2.67M -5.76% Stonepine Capital Management, LLC 30 Sep 2025
APRE Aprea Therapeutics, Inc. Common Stock 4.3% $419K -$82.2K 239K -16.4% Stonepine Capital Management, LLC 31 Mar 2025
INO Inovio Pharmaceuticals, Inc. Common Stock 3.8% $2.68M -$901K 1.43M -25.1% Stonepine Capital Management, LLC 31 Mar 2025

Schedules 13D/G Reported by Stonepine Capital Management, LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.